Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapy.


BACKGROUND Chronic kidney disease (CKD) is a common co-morbidity of patients with atherosclerotic vascular disease, and may influence the response to antiplatelet therapy. We, therefore, sought to investigate its effect on platelet activation and on-treatment residual platelet reactivity. METHODS We assessed platelet activation and the response to… (More)
DOI: 10.1093/ndt/gft103


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics